Royal Bank of Canada
NDRA icon

Royal Bank of Canada’s ENDRA Life Sciences NDRA Stock Holding History

Royal Bank of Canada’s Portfolio NDRA Stock Details NDRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Hold
0
– -$2K – 7519
2023
Q1 		– Hold
0
– – – 6783
2022
Q4 		– Hold
0
– – – 6866
2022
Q3 		– Hold
0
– – – 6738
2022
Q2 		– Hold
0
– – – 6736
2022
Q1 		– Hold
0
– – – 7187
2021
Q4 		– Hold
0
– – – 7029
2021
Q3 		– Sell
-1
Closed -$63.9K – 6552
2021
Q2 		$55K Buy
+1
New +$78.7K ﹤0.01% 5973
2021
Q1 		– Hold
0
– – – 6026
2020
Q3 		– Hold
0
– -$3K – 6824
2020
Q2 		– Hold
0
– – – 6196
2020
Q1 		– Hold
0
– – – 6312
2019
Q4 		– Hold
0
– – – 6359
2019
Q3 		– Hold
0
– – – 6206
2019
Q2 		– Hold
0
– – – 6314
2019
Q1 		– Hold
0
– – – 6269

Other funds holding NDRA

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
NA
NewEdge Advisors New Orleans, Louisiana $27.7B AUM 22.98% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
TSS
Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
HF
HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
WAM
Worth Asset Management Dallas, Texas $313M AUM 37.93% 1-Year Est. Return

Royal Bank of Canada's NDRA Position: Q2 2023 in Review

Royal Bank of Canada held its ENDRA Life Sciences (NDRA) position steady in Q2 2023 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7519.

Royal Bank of Canada first reported a position in NDRA in Q2 2021 and has held it in 1 quarter since. The position peaked at $55K in Q2 2021. 8 funds tracked by Wall St. Rank hold NDRA as of Q2 2023.

  • Royal Bank of Canada held 0 shares of ENDRA Life Sciences worth $0 as of Q2 2023.
  • Royal Bank of Canada left its ENDRA Life Sciences share count unchanged in Q2 2023.
  • ENDRA Life Sciences made up ﹤0.01% of Royal Bank of Canada's portfolio in Q2 2023, its #7519 holding.
  • Royal Bank of Canada first reported a position in ENDRA Life Sciences in Q2 2021 and has held it in 1 quarter since.
  • Royal Bank of Canada's ENDRA Life Sciences position peaked at $55K in Q2 2021.
  • 8 funds tracked by Wall St. Rank held ENDRA Life Sciences as of Q2 2023.

Based on Royal Bank of Canada's 13F filing for Q2 2023, filed 14 Aug 2023.